Tumor-Infiltrating Lymphocytes in Advanced Melanoma | NEJM
Рет қаралды 5,242
Жыл бұрынAdoptive cell therapy with tumor-infiltrating lymphocytes, or TIL therapy, showed promise in patients with advanced melanoma in phase 1-2 trials, but additional data were needed.
New research findings are summarized in a short video.
To see the full article, follow this link: nej.md/3UsKn3e
@wolfpytlak2786 Жыл бұрын
If neutropenia was to be expected as part of TIL, while it should be measured, it shouldn't have been grouped with the rest of the adverse effect (the incidence of infections, bleedings and dyspnea/fatigue, and other complications would be more relevant)
@insertname5421 Жыл бұрын
please, never bring this to the market FAST. It is not like this is known since 1980s, people still love dying of cancer.
Scary Teacher 3D Gaming
Рет қаралды 53 МЛН
Jason Derulo
Рет қаралды 53 МЛН
Ohio State Wexner Medical Center
Рет қаралды 596
International Immuno-Oncology Biomarker WG on BC
Рет қаралды 3 М.
Queen's Health Sciences
Рет қаралды 4,1 М.
The Patient Story
Рет қаралды 10 М.